Search

Your search keyword '"Heidecke, Harald"' showing total 339 results

Search Constraints

Start Over You searched for: Author "Heidecke, Harald" Remove constraint Author: "Heidecke, Harald"
339 results on '"Heidecke, Harald"'

Search Results

2. Severe COVID-19 patients exhibit elevated levels of autoantibodies targeting cardiolipin and platelet glycoprotein with age: a systems biology approach

4. Autoantibodies targeting G protein-coupled receptors: An evolving history in autoimmunity. Report of the 4th international symposium

5. Integrative Systems Immunology Analysis Reveals Elevated Anti-AGTR1 Levels with Accumulating COVID-19 Symptoms

9. Clinical and Diagnostic Features of Post-Acute COVID-19 Vaccination Syndrome (PACVS).

13. Allergic manifestations in women with silicone breast implants

15. Protease-Activated Receptor-1 IgG Autoantibodies in Patients with COVID-19

16. Autoantibodies against the chemokine receptor 3 predict cardiovascular risk

17. Autoantibodies from patients with kidney allograft vasculopathy stimulate a proinflammatory switch in endothelial cells and monocytes mediated via GPCR-directed PAR1-TNF-α signaling

18. Chronic Fatigue and Dysautonomia following COVID-19 Vaccination Is Distinguished from Normal Vaccination Response by Altered Blood Markers

20. Chronic Fatigue and Dis-Autonomy following COVID-19 Vaccination is Distinguished from Normal Vaccination Response by Altered Blood Markers

26. Intensive receptor blockade and plasma exchange to treat refractory scleroderma renal crisis in patients with agonistic autoantibodies targeting the angiotensin II type 1 and endothelin-1 type A receptors

27. Ambrisentan, an endothelin receptor type A-selective antagonist, inhibits cancer cell migration, invasion, and metastasis

29. Nailfold Videocapillaroscopy for Non-Invasive Assessment of Microcirculation and Prognostic Correlation with Endothelial Dysfunction, Cardiovascular Risk Factors, and Non-HLA Antibodies in Heart Transplant Recipients: A Pilot Study

31. Cross‐sectional analysis reveals autoantibody signatures associated with COVID‐19 severity

32. Receptor autoantibodies: Associations with cardiac markers, histology, and function in human non‐ischaemic heart failure

34. sj-pdf-2-jso-10.1177_23971983231168193 – Supplemental material for Intensive receptor blockade and plasma exchange to treat refractory scleroderma renal crisis in patients with agonistic autoantibodies targeting the angiotensin II type 1 and endothelin-1 type A receptors

35. sj-pdf-1-jso-10.1177_23971983231168193 – Supplemental material for Intensive receptor blockade and plasma exchange to treat refractory scleroderma renal crisis in patients with agonistic autoantibodies targeting the angiotensin II type 1 and endothelin-1 type A receptors

36. Low avidity circulating SARS-CoV-2 reactive CD8+ T cells with proinflammatory TEMRA phenotype are associated with post-acute sequelae of COVID-19

37. GPCR-specific autoantibody signatures are associated with physiological and pathological immune homeostasis

38. Increased migratory/activated CD8+ T cell and low avidity SARS-CoV-2 reactive cellular response in post-acute COVID-19 syndrome

39. SARS-CoV-2 infection induces the production of autoantibodies in severe COVID-19 patients in an age-dependent manner

40. Low concentrations of C5a complement receptor antibodies are linked to disease activity and relapse in ANCA ‐associated vasculitis

41. Increased protease-activated receptor 1 autoantibodies are associated with severe COVID-19

42. Dysregulated autoantibodies targeting vaso- and immunoregulatory receptors in Post COVID Syndrome correlate with symptom severity

44. Low Concentrations of C5a Complement Receptor Antibodies Are Linked to Disease Activity and Relapse in Antineutrophil Cytoplasmic Autoantibody–Associated Vasculitis.

46. Antibodies against chemokine receptors CXCR3 and CXCR4 predict progressive deterioration of lung function in patients with systemic sclerosis

47. Endothelin B Receptor Immunodynamics in Pulmonary Arterial Hypertension

49. Induced antibodies directed to the angiotensin receptor type 1 provoke skin and lung inflammation, dermal fibrosis and act species overarching

Catalog

Books, media, physical & digital resources